Educational Activities

Obesity is transforming the landscape of inflammatory bowel disease (IBD), shaping disease activity, treatment response, and long-term prognosis. As evidence reveals the impact of excess weight on biologic and JAK inhibitor effectiveness, emerging anti-obesity therapies, including GLP-1 receptor agonists, are creating new opportunities to improve patient outcomes. To stay ahead of this rapidly evolving field, gastroenterologists and multidisciplinary care teams need timely, evidence-based education to confidently integrate obesity management into personalized, stigma-free IBD care.

This fast-paced and highly interactive livestream CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how the immunometabolic impact of visceral and mesenteric adiposity on disease activity, treatment response, and surgical risk translates into practice, what doesn’t translate, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply validated adiposity assessment methods, confidently integrate GLP-1 RAs into individualized treatment planning, and deliver patient-centered IBD care.

This event is neither sponsored by nor endorsed by ACG. 

This fast-paced and highly interactive live CaseWise™ webcast from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will explore key clinical challenges to help sharpen diagnostic confidence, individualize treatment, and help patients achieve better long-term outcomes.

This fast-paced and highly interactive recorded CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply guideline-recommended diagnostic criteria and comprehensive assessments into practice when there is clinical suspicion of IH to improve early and accurate diagnosis.

To address these challenges, this activity uses a series of interactive “Time-Outs” – brief, case-based discussions in which expert faculty pause at key clinical decision points to examine the rationale behind their approaches. Each Time-Out focuses on a common diagnostic or therapeutic dilemma in CLL care, highlighting how biomarker findings, patient characteristics, and evolving clinical evidence inform evidence-based decision-making.

This CME Outfitters recorded webcast makes that pathway clear and approachable, with expert faculty modeling how to fold baseline assessment into real-world workflows. It brings together perspectives from across the care team, including academic experts, community providers, gastroenterology, cardiology, and nurse practitioners, so the guidance translates for all providers.

In this CME Outfitters AI-powered precision learning activity, expert faculty will apply burden and acuity indicators to classify UTI presentations as localized vs systemic and anticipate downstream site-of-care and resource implications. Learners will be shown how to construct evidence-based empiric and targeted treatment regimens for multi-drug-resistant pathogens by integrating updated clinical algorithms and novel antimicrobial data. Faculty will model implementation of stewardship-driven transition protocols for cUTI, including site-of-care decisions and discharge planning to reduce avoidable readmission.